Correlation Between Walker Dunlop and Neovacs SA

Can any of the company-specific risk be diversified away by investing in both Walker Dunlop and Neovacs SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Walker Dunlop and Neovacs SA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Walker Dunlop and Neovacs SA, you can compare the effects of market volatilities on Walker Dunlop and Neovacs SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Walker Dunlop with a short position of Neovacs SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Walker Dunlop and Neovacs SA.

Diversification Opportunities for Walker Dunlop and Neovacs SA

-0.39

Correlation Coefficient

Walker Dunlop  Neovacs SA

Very good diversification

The 3 months correlation between Walker and Neovacs is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Walker Dunlop and Neovacs SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neovacs SA and Walker Dunlop is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Walker Dunlop are associated (or correlated) with Neovacs SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neovacs SA has no effect on the direction of Walker Dunlop i.e., Walker Dunlop and Neovacs SA go up and down completely randomly.

Pair Corralation between Walker Dunlop and Neovacs SA

Allowing for the 90-day total investment horizon Walker Dunlop is expected to generate 6.17 times less return on investment than Neovacs SA. But when comparing it to its historical volatility, Walker Dunlop is 14.3 times less risky than Neovacs SA. It trades about 0.06 of its potential returns per unit of risk. Neovacs SA is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  0.07  in Neovacs SA on September 3, 2024 and sell it today you would lose (0.05) from holding Neovacs SA or give up 71.43% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

Walker Dunlop  vs.  Neovacs SA

Walker Dunlop

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Walker Dunlop are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, Walker Dunlop is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Neovacs SA

Risk-Adjusted Performance

2 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Neovacs SA are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Neovacs SA reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Walker Dunlop and Neovacs SA

The main advantage of trading using opposite Walker Dunlop and Neovacs SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Walker Dunlop position performs unexpectedly, Neovacs SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neovacs SA will offset losses from the drop in Neovacs SA's long position.

The idea behind Walker Dunlop and Neovacs SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.